Literature DB >> 20031267

Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution.

Manreet Kanwar1, Charlene B Irvin, John J Frank, Kathryn Weber, Howard Rosman.   

Abstract

Epinephrine is indicated for various medical emergencies, including cardiac arrest and anaphylaxis, but the dose and route of administration are different for each indication. For anaphylaxis, it is given intramuscularly at a low dose, whereas for cardiac arrest a higher dose is required intravenously. We encountered a patient with suspected anaphylaxis who developed transient severe systolic dysfunction because of inappropriately received cardiac arrest dose, ie, larger dose given as an intravenous push. Three additional patients who experienced potentially lethal cardiac complications after receiving inappropriately higher doses intravenously were also identified. These iatrogenic errors resulted from underlying confusion by physicians about proper dosing of epinephrine for anaphylaxis. The risk of error was amplified by the need for rapid decision making in critically ill anaphylactic patients. An e-mail survey of local hospitals in southeast Michigan revealed that 6 of 7 hospitals did not stock prefilled intramuscular dose syringes for emergency use in anaphylaxis. At our institution, we have introduced prefilled and appropriately labeled intramuscularly dosed epinephrine syringes in crash carts, which are easily distinguished from intravenously dosed epinephrine syringes. In this Concepts article, we describe the clinical problem of inadvertent epinephrine overdose and propose a potential solution. Epinephrine must be clearly packaged and labeled to avoid inappropriate usage and unnecessary, potentially lethal complications in patients with anaphylaxis. Copyright (c) 2009 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20031267     DOI: 10.1016/j.annemergmed.2009.11.008

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  22 in total

1.  Anaphylaxis: A review and update.

Authors:  Jennifer Tupper; Shaun Visser
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275

2.  Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.

Authors:  Tiansheng Wang; Xiang Ma; Yan Xing; Shusen Sun; Hua Zhang; Til Stürmer; Bin Wang; Xiaotong Li; Huilin Tang; Ligong Jiao; Suodi Zhai
Journal:  Int Arch Allergy Immunol       Date:  2017-05-16       Impact factor: 2.749

3.  Early Use of ECMO for Refractory Kounis Syndrome Concealed by General Anesthesia-A Case Report.

Authors:  Ho Kyung Yu; Miyeong Park; Soo Hee Lee; Jung-Woo Woo; Dong-Hoon Kang; Joung Hun Byun; Seong-Ho Ok
Journal:  Medicina (Kaunas)       Date:  2022-06-02       Impact factor: 2.948

4.  A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department.

Authors:  Veena Manivannan; Erik P Hess; Venkatesh R Bellamkonda; David M Nestler; M Fernanda Bellolio; John B Hagan; Kharmene L Sunga; Wyatt W Decker; James T C Li; Lori N Scanlan-Hanson; Samuel C Vukov; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2014-02-16

Review 5.  Safety of epinephrine for anaphylaxis in the emergency setting.

Authors:  Joseph P Wood; Stephen J Traub; Christopher Lipinski
Journal:  World J Emerg Med       Date:  2013

6.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

Review 7.  Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

Review 8.  CSACI position statement: epinephrine auto-injectors and children < 15 kg.

Authors:  Michelle Halbrich; Douglas P Mack; Stuart Carr; Wade Watson; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2015-06-12       Impact factor: 3.406

9.  First-Line Vasopressor and Mortality Rates in ED Patients with Acute Drug Overdose.

Authors:  Christopher Clifford; Monica Sethi; Dalton Cox; Alex F Manini
Journal:  J Med Toxicol       Date:  2020-07-11

10.  ACE-I Angioedema: Accurate Clinical Diagnosis May Prevent Epinephrine-Induced Harm.

Authors:  R Mason Curtis; Sarah Felder; Rozita Borici-Mazi; Ian Ball
Journal:  West J Emerg Med       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.